Skip to main content
AMTB logo

AMTB · Amerant Bancorp Inc. · Financials

Track AMTB — free
$28.34 -0.58 (-2.01%) At close · Nov 19 Play latest call Q3 2026 earnings call transcript
Market Cap
$1.11B
Shares
39.02M
Volume · Nov 19 321.39K Avg daily vol (3M) 361.17K

Income-statement, balance-sheet and cash-flow figures from SEC filings, plus a debt profile anchored in the latest 10-K and updated by each 10-Q and debt exhibit.

Revenue
$439.3M +30.8%
FY2025 Revenue FY2016–FY2025
Net Income
$52.42M +432.8%
FY2025 Net Income FY2016–FY2025
Diluted EPS
$1.26 +386.4%
FY2025 Diluted EPS FY2016–FY2025
Operating Cash Flow
$136.98M +66.7%
FY2025 Operating Cash Flow FY2016–FY2025

Chart any reported metric, KPI or segment over time — the full statement history lives here

Line Item TTM FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018 FY2017 FY2016
$419.37M $439.3M $335.87M $413.96M $333.94M $325.76M $263.02M $270.2M $272.91M $281.2M $254.2M
$557.26M $597.43M $595.59M $548.58M $338.78M $247.84M $260.55M $312.97M $309.36M $273.32M $238.83M
$343.47M $360.69M $325.96M $326.46M $266.67M $205.14M $189.55M $213.09M $219.04M $209.71M $191.93M
$75.9M $78.61M $9.91M $87.5M $67.28M $120.62M $73.47M $57.11M $53.88M $71.49M $62.27M
$6.45M $6.69M $6.6M $6.84M $5.88M $7.27M $9.39M $7.09M $8.54M $9.04M $9.13M
$213.79M $236.74M $269.63M $222.12M $72.11M $42.7M $71M $99.89M $90.32M $63.61M $46.89M
— — — $100K $200K — — — — — —
$85.47M $66.14M -$24.08M $41.33M $78.58M $144.02M -$4.33M $64.03M $57.57M $77.05M $33.79M
$18.13M $13.72M -$8.33M $10.54M $16.62M $33.71M -$2.61M $12.7M $11.73M $33.99M $10.21M
$67.33M $52.42M -$15.75M $32.49M $63.31M $112.92M -$1.72M $51.33M $45.83M $43.06M $23.58M
— 11.93% -4.69% 7.85% 18.96% 34.66% -0.65% 19% 16.79% 15.31% 9.28%
— $0 $0 -$1.7M -$1.35M -$2.61M $0 $0 — — —
-$44.61M $91.35M $15.24M $42.33M -$32.54M $96.47M $16.71M $82.73M $33.8M $47.62M $22.33M
USD/shares $1.72 $1.26 -$0.44 $0.97 $1.87 $3.04 -$0.04 $1.21 $1.08 $1.01 $0.55
USD/shares $1.70 $1.26 -$0.44 $0.96 $1.85 $3.01 -$0.04 $1.20 $1.08 $1.01 $0.55
shares — 41.58M 35.76M 33.51M 33.86M 37.17M 41.74M 42.54K 42.49K 42.49K 42.49M
shares — 41.73M 35.76M 33.68M 34.14M 37.53M 41.74M 42.94K 42.49K 42.49K 42.49M
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.

Capital Returned to Shareholders

Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2016–FY2025: $153.88M in buybacks, $92.21M in dividends.

Debt Profile

Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.

Read debt and covenant terms in your AI or your code through MCP and the API →

Reported debt balances

Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.

Reported balanceAs ofAmountSource
Advances from Federal Home Loan Banks 2026-09-30 USD 715,000,000 10-Q filed 2026-11-03
Noncurrent operating lease liabilities 2026-09-30 USD 113,939,000 10-Q filed 2026-11-03
Instrument and agreement coverage is incomplete. Additional filings are awaiting review.
1 filing has incomplete source or extraction coverage. Verified observations are shown; missing observations do not establish that debt was unchanged.

Covenants

Covenant terms have not yet been verified for this profile.

The balance figures do not establish whether covenants apply or whether the company complies with them.

Loans, facilities and notes

7.00% Senior Notes due 2031

Note · Amerant Bancorp Inc.

Reference: 7.00% Senior Notes due 2031

Active
Original principal
USD 50,000,000
Outstanding
—
Commitment
—
Availability
—
Maturity
Sep 17, 2031

Last reported interest terms: 7% 7.00% per annum, payable semi-annually in arrears on March 17 and September 17 of each year, commencing on March 17, 2027. Reported 2026-09-17 Later filings may not restate these terms; this does not confirm they still apply.

Covenant terms for this agreement are not yet verified.

Documents and filing history
  1. Issuance · 2026-09-17 Original principal USD 50,000,000 Exact source document Parent 8-K filing · 2026-09-17
    On September 14, 2026, Amerant Bancorp Inc. (the “Company”) entered into an underwriting agreement (the “Underwriting Agreement”) with Raymond James & Associates, Inc. (the “Underwriter”) providing for the offer and sale of the Company's $50 million aggregate principal amount of 7.00% Senior Notes due 2031 (the “Notes”) pursuant to an automatic shelf registration statement on Form S-3ASR (File No. 333-296741) filed with and automatically effective upon filing with Securities and Exchange Commission on June 12, 2026 (the “Registration Statement”). The Company made customary representations, warranties and covenants in the Underwriting Agreement concerning the Company and the Registration Statement. The Company agreed to indemnify the Underwriter against certain liabilities, including liabilities under the Securities Act of 1933, as amended. On September 17, 2026, the Company completed its previously announced registered public offering (the “Offering”) of the Notes.
    Issuer evidence: On September 14, 2026, Amerant Bancorp Inc. (the “Company”) entered into an underwriting agreement (the “Underwriting Agreement”) with Raymond James & Associates, Inc. (the “Underwriter”) providing for the offer and sale of the Company's $50 million aggregate principal amount of 7.00% Senior Notes due 2031 (the “Notes”) pursuant to an automatic shelf registration statement on Form S-3ASR (File No. 333-296741) filed with and automatically effective upon filing with Securities and Exchange Commission on June 12, 2026 (the “Registration Statement”). The Company made customary representations, warranties and covenants in the Underwriting Agreement concerning the Company and the Registration Statement. The Company agreed to indemnify the Underwriter against certain liabilities, including liabilities under the Securities Act of 1933, as amended. On September 17, 2026, the Company completed its previously announced registered public offering (the “Offering”) of the Notes.
    Supporting evidence: The Notes bear interest at 7.00% per annum, payable semi-annually in arrears on March 17 and September 17 of each year, commencing on March 17, 2027. The Notes are unsecured and unsubordinated, rank equally in priority among themselves and with all of the Company’s other existing and future unsecured and unsubordinated indebtedness, and are senior in right of payment to all of the Company's existing and future subordinated indebtedness. The Notes will mature on September 17, 2031.
    Supporting evidence: The Notes were issued pursuant to the Base Indenture, dated as of September 17, 2026 (the “Base Indenture”), by and between the Company and The Bank of New York Mellon, as trustee (the “Trustee”), as supplemented by a First Supplemental Indenture, dated as of September 17, 2026 (the “Supplemental Indenture” and, together with the Base Indenture, the “Indenture”), by and between the Company and the Trustee.
    Supporting evidence: On September 14, 2026, Amerant Bancorp Inc. (the “Company”) entered into an underwriting agreement (the “Underwriting Agreement”) with Raymond James & Associates, Inc. (the “Underwriter”) providing for the offer and sale of the Company's $50 million aggregate principal amount of 7.00% Senior Notes due 2031 (the “Notes”) pursuant to an automatic shelf registration statement on Form S-3ASR (File No. 333-296741) filed with and automatically effective upon filing with Securities and Exchange Commission on June 12, 2026 (the “Registration Statement”). The Company made customary representations, warranties and covenants in the Underwriting Agreement concerning the Company and the Registration Statement. The Company agreed to indemnify the Underwriter against certain liabilities, including liabilities under the Securities Act of 1933, as amended. On September 17, 2026, the Company completed its previously announced registered public offering (the “Offering”) of the Notes.

Price & Valuation

Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.

Valuation

EV/Revenue
—
Peer median 3.48×
EV/EBIT
—
P/E (TTM)
16.81×
Peer median 11.45×
Price/Sales (TTM)
2.64×
Peer median 3.35×
Price/Book
1.32×
Peer median 1.22×

Peer medians compare against the 285 similar-size Banks - Regional companies (of 349 listed).

Valuation over time computed as of each quarter's filing date

Key facts CIK 1734342 CUSIP 023576101 13F (30d) 158 filings 141 filers Visit website Investor relations